Back to FIRST MANHATTAN CO. LLC. FIRST MANHATTAN CO. LLC.

VIVOVIVO

Showing 0 of 18 quarters

Position history for FIRST MANHATTAN CO. LLC.FIRST MANHATTAN CO. LLC.'s holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, First Manhattan held 2,562 shares of VIVO (Meridian Bioscience), worth $85,084. First Manhattan's 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used